Viral etiology of acute exacerbations of COPD in Hong Kong

Fanny W S Ko, Margaret Ip, Paul K S Chan, Michael C H Chan, Kin-Wang To, Susanna S S Ng, Shirley S L Chau, Julian W Tang, David S C Hui, Fanny W S Ko, Margaret Ip, Paul K S Chan, Michael C H Chan, Kin-Wang To, Susanna S S Ng, Shirley S L Chau, Julian W Tang, David S C Hui

Abstract

Introduction: Viral respiratory infections may precipitate acute exacerbations of COPD (AECOPD). However, little is known about viral etiology related to AECOPD in Asia. We aimed to study the viral etiology of AECOPD in Hong Kong.

Methods: Patients admitted to an acute hospital in Hong Kong with AECOPD were recruited prospectively from May 1, 2004, to April 30, 2005. Nasopharyngeal aspirate was collected and assessed by polymerase chain reaction (PCR) and viral culture. Spirometry was performed in the stable phase at 2 to 3 months after hospital discharge.

Results: There were 262 episodes of AECOPD among 196 patients (mean age, 75.7 +/- 7.7 years [+/- SD]; 160 men). Mean FEV(1) was 39.6 +/- 18.9% of predicted normal, and FEV(1)/FVC ratio was 58.0 +/- 15.2%. Fifty-eight episodes (22.1%) yielded positive viral PCR results. The viruses identified were influenza A (7.3%), coronavirus OC43 (4.6%), rhinovirus (3.1%), influenza B (2.7%), and respiratory syncytial virus (2.3%). The diagnostic yield of viral identification by PCR was 2.7 times higher than that based on conventional viral culture. The rates of identifying a positive viral etiology by PCR were similar among the subjects with FEV(1) >or= 50%, >or= 30 to 50%, and < 30% of predicted normal. Viral infection appeared to have no effect on subsequent readmissions or mortality rate over a study period of 1 year

Conclusion: Influenza A and two less-attended viruses, coronavirus OC43 and rhinovirus, were the common etiologic agents in patients hospitalized with AECOPD in Hong Kong. These should be considered in developing diagnostic and intervening strategies pertaining to AECOPD.

Figures

Figure 1
Figure 1
Viruses as detected by PCR method in the nasopharyngeal aspirates of patients (n = 262).
Figure 2
Figure 2
Seasonal pattern of viruses for patients admitted with acute exacerbation of COPD.

References

    1. Global Initiative for Chronic Obstructive Lung Disease: global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease; updated 2006. National Heart, Lung, and Blood Institute, World Health Organization; Bethesda, MD: 2006.
    1. Seemungal TA, Donaldson GC, Paul EA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1418–1422.
    1. Donaldson GC, Seemungal TA, Bhowmik A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847–852.
    1. Ko FW, Ng TK, Li TS. Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong. Respir Med. 2005;99:454–460.
    1. Sethi S. Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon? Proc Am Thorac Soc. 2004;1:109–114.
    1. Wedzicha JA. Role of viruses in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2004;1:115–120.
    1. Anderson HR, Spix C, Medina S. Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. Eur Respir J. 1997;10:1064–1071.
    1. Wouters EF, Postma DS, Fokkens B. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial. Thorax. 2005;60:480–487.
    1. Donaldson GC, Seemungal T, Jeffries DJ. Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. Eur Respir J. 1999;13:844–849.
    1. Ko FW, Ip M, Chan PK. A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD. Chest. 2007;131:44–52.
    1. Global Initiative for Chronic Obstructive Lung Disease: global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease; updated 2004. National Heart, Lung, and Blood Institute, World Health Organization; Bethesda, MD: 2004.
    1. Patel IS, Seemungal TA, Wilks M. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax. 2002;57:759–764.
    1. Charlson ME, Pompei P, Ales KL. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
    1. Bellau-Pujol S, Vabret A, Legrand L. Development of three multiplex RT-PCR assays for the detection of 12 respiratory RNA viruses. J Virol Methods. 2005;126:53–63.
    1. Billaud G, Peny S, Legay V. Detection of rhinovirus and enterovirus in upper respiratory tract samples using a multiplex nested PCR. J Virol Methods. 2003;108:223–228.
    1. Coiras MT, Aguilar JC, Garcia ML. Simultaneous detection of fourteen respiratory viruses in clinical specimens by two multiplex reverse transcription nested-PCR assays. J Med Virol. 2004;72:484–495.
    1. Cote S, Abed Y, Boivin G. Comparative evaluation of real-time PCR assays for detection of the human metapneumovirus. J Clin Microbiol. 2003;41:3631–3635.
    1. Grondahl B, Puppe W, Hoppe A. Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: feasibility study. J Clin Microbiol. 1999;37:1–7.
    1. Templeton KE, Scheltinga SA, Beersma MF. Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4. J Clin Microbiol. 2004;42:1564–1569.
    1. Vijgen L, Keyaerts E, Moes E. Development of one-step, real-time, quantitative reverse transcriptase PCR assays for absolute quantitation of human coronaviruses OC43 and 229E. J Clin Microbiol. 2005;43:5452–5456.
    1. Xu W, McDonough MC, Erdman DD. Species-specific identification of human adenoviruses by a multiplex PCR assay. J Clin Microbiol. 2000;38:4114–4120.
    1. Xu W, Erdman DD. Type-specific identification of human adenovirus 3, 7, and 21 by a multiplex PCR assay. J Med Virol. 2001;64:537–542.
    1. American Thoracic Society Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152:1107–1136.
    1. Ip MS, Ko FW, Lau AC. Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization. Chest. 2006;129:384–392.
    1. Seemungal T, Harper-Owen R, Bhowmik A. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:1618–1623.
    1. Rohde G, Wiethege A, Borg I. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax. 2003;58:37–42.
    1. Cameron RJ, de Wit D, Welsh TN. Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation. Intensive Care Med. 2006;32:1022–1029.
    1. Tan WC, Xiang X, Qiu D. Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med. 2003;115:272–277.
    1. Dominici F, Peng RD, Bell ML. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA. 2006;295:1127–1134.
    1. Medina-Ramon M, Zanobetti A, Schwartz J. The effect of ozone and PM10 on hospital admissions for pneumonia and chronic obstructive pulmonary disease: a national multicity study. Am J Epidemiol. 2006;163:579–588.
    1. Wilkinson TM, Hurst JR, Perera WR. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest. 2006;129:317–324.
    1. Gern JE, Galagan DM, Jarjour NN. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med. 1997;155:1159–1161.
    1. Fleming HE, Little FF, Schnurr D. Rhinovirus-16 colds in healthy and in asthmatic subjects: similar changes in upper and lower airways. Am J Respir Crit Care Med. 1999;160:100–108.
    1. Papadopoulos NG, Bates PJ, Bardin PG. Rhinoviruses infect the lower airways. J Infect Dis. 2000;181:1875–1884.
    1. Center for Health Protection, Government of the Hong Kong Special Administrative Region. Monthly summary tables of influenza virus isolation 2006. Available at: . Accessed July 25, 2007
    1. Center for Health Protection, Government of Hong Kong Special Administration Region. Monthly consultation rates of influenza-like illness reported by general out-patient clinics and general practitioners 2006. Available at: . Accessed July 25, 2007
    1. Thompson WW, Shay DK, Weintraub E. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333–1340.
    1. Thompson WW, Shay DK, Weintraub E. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–186.
    1. Beckham JD, Cadena A, Lin J. Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect. 2005;50:322–330.
    1. Greenberg SB, Allen M, Wilson J. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162:167–173.
    1. Rohde G, Borg I, Arinir U. Relevance of human metapneumovirus in exacerbations of COPD. Respir Res. 2005;6:150.
    1. Martinello RA, Esper F, Weibel C. Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease. J Infect. 2006;53:248–254.
    1. Smith CB, Golden CA, Kanner RE. Association of viral andMycoplasma pneumoniaeinfections with acute respiratory illness in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis. 1980;121:225–232.
    1. Yap FH, Ho PL, Lam KF. Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong. J Med Virol. 2004;73:617–623.
    1. Wongsurakiat P, Maranetra KN, Wasi C. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest. 2004;125:2011–2020.
    1. Govaert TM, Thijs CT, Masurel N. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA. 1994;272:1661–1665.
    1. Nichol KL, Margolis KL, Wuorenma J. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994;331:778–784.
    1. Falsey AR, Formica MA, Hennessey PA. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173:639–643.
    1. Mallia P, Johnston SL. How viral infections cause exacerbation of airway diseases. Chest. 2006;130:1203–1210.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться